G6PD and Plasmodium vivax malaria: Primaquine, at a low dose of 3.5mg/kg, has been recommended in the Cambodian National Treatment Guidelines since 2014 as a treatment for vivax malaria in patients with confirmed G6PD normal status, while deficient individuals were not to receive primaquine [15–17].